Ticker: WX, Company: WuXi PharmaTech (Cayman) Inc., Type: 20-F, Date: 2011-04-27, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: WX/20110427/20-F/1/000.htm SEC Original: d20f.htm
TABLE OF CONTENTS Page INTRODUCTION 1 2 PART I. ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 24 ITEM 4A. UNRESOLVED STAFF COMMENTS 42 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 42 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND

---

---

Webplus: WX/20110427/20-F/2_EX-8.1/000.htm SEC Original: dex81.htm
LIST OF SUBSIDIARIES • • WX (BVI) Limited, incorporated in the British Virgin Islands. • WuXi AppTec (BVI) Inc., incorporated in the British Virgin Islands. • • Shanghai AppTec(HK) Limited, incorporated in HongKong. • Kaipara Enterprises Limited, incorporated in Cyprus. • Klivia Investments Sp. zo.o., incorporated in Poland. • Klivia Investments Sp. zo.o. Luxembourg Branch, incorporated in Luxembourg. • WuXi

---

---

Webplus: WX/20110427/20-F/3_EX-12.1/000.htm SEC Original: dex121.htm
Certification I, Ge Li, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based

---

---

Webplus: WX/20110427/20-F/4_EX-12.2/000.htm SEC Original: dex122.htm
Certification I, Edward Hu, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based

---

---

Webplus: WX/20110427/20-F/5_EX-13.1/000.htm SEC Original: dex131.htm
Certification Ge Li Chief Executive Officer EX-13.1 5 dex131.htm CERTIFICATION

---

---

Webplus: WX/20110427/20-F/6_EX-13.2/000.htm SEC Original: dex132.htm
Certification Edward Hu Chief Financial Officer EX-13.2 6 dex132.htm CERTIFICATION

---

---

Webplus: WX/20110427/20-F/7_EX-23.1/000.htm SEC Original: dex231.htm
April 27, 2011 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People’s Republic of China RE: WUXI PHARMATECH (CAYMAN) INC. Dear Sirs/Madams, Company We have acted as legal advisors as to the laws of the People’s Republic of China to WuXi PharmaTech (Cayman) Inc., an exempted limited liability company incorporated in the Cayman Islands

---

---

Webplus: WX/20110427/20-F/8_EX-23.2/000.htm SEC Original: dex232.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-146730 on Form S-8 and in Registration Statement No. 333-161757 on Form F-3 of our reports dated April 26, 2011, relating to the consolidated financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc., and the effectiveness WuXi PharmaTech (Cayman) Inc.’s

---

Company Information:

Ticker: WX, Company: WuXi PharmaTech (Cayman) Inc., Type: 20-F, Date: 2011-04-27, XBRL Interactive FinancialsCIK: 0001403132, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
288 FUTE ZHONG ROAD
SHANGHAI 200131